MSLN and acute myeloid leukemia: We tested the specificity and efficacy of the MSLN-targeting BsAbs in vitro and in disseminated xenograft models of KMT2A-rearranged pediatric AML, because it is one of the major subtypes with predominant MSLN expression [8].